Table 2.
Demographic and laboratory characteristics of the included participants.
| Characteristics | Overall |
|---|---|
| Age, mean±std years | 55.7±15.3 |
| Gender, n (%) | |
| Male | 1257 (51.2) |
| Female | 1196 (48.8) |
| Laboratory test, means±sd, | |
| Hs-CRP (mg/L) | 32.28±47.81 |
| PCT (ng/mL) | 0.23±1.59 |
| IL-6 (pg/ml) | 28.97±220.67 |
| IL-1 (pg/ml) | 6.45±7.84 |
| TNF-α (pg/ml) | 8.73±4.49 |
| IL-2R (U/mL) | 599.45±411.67 |
| IL-8 (pg/ml) | 19.25±38.75 |
| IL-10 (pg/ml) | 6.50±5.93 |
| PT (s) | 13.87±1.44 |
| PTA (%) | 92.40±13.10 |
| APTT (s) | 39.60±6.96 |
| Tt (s) | 16.82±4.19 |
| INR | 1.07±0.15 |
| DD (μg/mL) | 1.86±4.07 |
| FIB (g/L) | 4.47±1.46 |
| RBC(*10^12/L) | 4.67±2.9 |
| WBC (*10^9/L) | 6.59±6.73 |
| NEUTA (*10^9/L) | 4.06±2.37 |
| NEUTP (%) | 65.00±12.74 |
| LYMPHA (*10^9/L) | 1.34±0.61 |
| PLT (*10^9/L) | 227.75±89.83 |
| GLB (g/L) | 31.87±5.35 |
| ALT (U/L) | 30.51±33.24 |
| PAB (mg/L) | 209.31±87.52 |
| TBil (μmol/L) | 10.21±13.77 |
| TP (g/L) | 69.15±6.12 |
| AST(GOT) (U/L) | 30.32±25.12 |
| Urea (mmol/L) | 278.31±100.28 |
| UA (μmol/L) | 5.00±3.24 |
| Egfr (ml/min/1.73m^2) | 90.98±21.18 |
| CK (U/L) | 101.95±177.31 |